| Product |
Cat. # |
Stand. Range / Sensitivity |
Specimen |
Test Type |
Units |
| AFP (Alpha Fetoprotein) |
EIA1468 |
10-160 ng/ml |
serum, amino fluid |
Quant |
96 wells |
| AFP
(Alpha Fetoprotein) - extended Standard Range |
EIA4331 |
2.0 ng/ml |
serum |
Quant |
96 wells |
| CA 125 |
EIA3939 |
15 - 200 U/ml //
3.327 U/ml |
50 ul serum, plasma |
Quant |
96 wells |
| CA 125
(Ovarian Cancer) Antigen |
EIA1472 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 15-3 |
EIA3941 |
25-200 U/ml //
0.905 U/ml |
10 ul serum, plasma |
Quant |
96 wells |
| CA 15-3
(Breast Cancer) Antigen (BCA) |
EIA1473 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 19-9 |
EIA3940 |
15-240 U/ml /
0.888 U/ml |
10 ul serum, plasma |
Quant |
96 wells |
| CA 19-9
(Gastrointestinal Cancer) Antigen (GCA) |
EIA1474 |
5 U/ml |
serum |
Quant |
96 wells |
| CA 242 |
EIA2082 |
|
|
Quant |
96 wells |
| CA 72-4 |
CLA4730 |
|
|
Quant |
96 wells |
| CA 72-4 |
EIA3942 |
3-100 U/ml // < 0.311 |
20 ul serum, plasma |
Quant |
96 wells |
| CA-242
Elisa - Pancreatic-colo-rectal |
EIA4581 |
5 - 200 U/ml //
1 U/ml |
25 ul serum |
Quant |
96 wells |
| CEA |
EIA1868 |
0 - 100 ng/ml // 0.44 ng/ml |
50 ul serum / plasma |
Quant |
96 wells |
| CEA |
EIA1871 |
1.0 ng/ml |
serum |
Quant |
96 wells |
| Chromogranin
A Elisa |
EIA4521 |
31 - 830 ng/ml //
5 ng/ml |
25 ul serum |
Quant |
96 wells |
| Cyfra
21-1 |
CLA4731 |
3 - 50 ng/ml ///
0.03 ng/ml |
50 ul serum, heparin plasma |
Qual |
96 wells |
| Cyfra
21-1 Elisa |
EIA3943 |
3 - 50 ng/ml // <0.266 ng/ml |
50 ul serum/plasma |
Quant |
96 wells |
| FGF-23
(Fibrolast growth factor 23) (human intact) |
EIA4737 |
6-650 pg/mL ///
1.0 pg/mL |
150 uL plasma or cell culture
media |
Quant |
96 wells |
| NSE
(Neuron specific Enolase) (controls extra EIA4458) |
EIA2353 |
|
|
Quant |
96 wells |
| NSE
Elisa (controls included) |
EIA4610 |
4 - 100 ng/mL //
4 ng/mL. |
25 uL serum |
Quant |
96 wells |
| NT-proBNP
direct Elisa |
EIA4827 |
10-640 fmol/ml ///
3 fmol/ml |
50 ul serum, plasma |
Quant |
96 wells |
| PSA
(Prostate Specific Antigen) |
EIA1778 |
0.5 ng/ml |
serum |
Quant |
96 wells |
| PSA
(Prostate Specific Antigen) |
EIA4105 |
|
|
Quant |
96 wells |
| PSA free |
EIA1792 |
0.05 ng/ml |
serum |
Quant |
96 wells |
| PSA free |
EIA4189 |
0.75 - 12 ng/ml /
0.1 nng/ml |
25ul serum |
Quant |
96 wells |
| PSA
total |
EIA3719 |
1.56 - 25 ng/ml / 0.5 ng/ml |
25 ul |
Quant |
96 wells |
| PSA,
Total |
EIA3945 |
|
|
Quant |
96 wells |
| PSA,
Total (Prostate Specific Antigen) |
CLA4657 |
0.005 - 100 ng/ml ///
0.002 ng/ml |
50 ul serum |
Quant |
96 wells |
| S100
Elisa (not incl. controls,: order EIA4458) |
EIA4556 |
50 - 3500 ng/L //
<10 ng/L |
50 uL serum |
Quant |
96 wells |
| S100B
(human) Elisa |
EIA4555 |
50 - 2000 pg/ml //
5 pg/ml |
60 ul serum,plasma and tissue
culture |
Quant |
96 wells |
| TM-CA125
Elisa |
EIA5072 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CA15.3
Elisa |
EIA5068 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CA19.9
Elisa |
EIA5069 |
will follows ///
will follow |
|
Quant |
96 wells |
| TM-CA72.4
Elisa |
EIA5071 |
will follow ///
will follow |
|
Quant |
96 wells |
| TM-CYFRA21.1 |
EIA5070 |
3 - 50 ng/ml ///
0.15 ng/ml |
50 ul serum, plasma |
Quant |
96 wells |
| Tumor
Marker Control I (1 vial, 0.5 ml lyophilized) |
CTL4756 |
|
|
|
1 vial |
| Tumor
Marker Control II (1 vial, o.5 ml lyophilized) |
CTL4755 |
|
|
|
1 vial |
| UBC
(Urinary Bladder Cancer) Elisa |
EIA2355 |
|
urine |
Quant |
96 wells |
|
|
|
|
|
|